| 标题 |
Abstract 1822: Preclinical efficacy and safety of CS5008, a novel SSTR2×DLL3 bispecific antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor payload for small cell lung cancer and neuroendocrine tumors |
| 网址 | |
| DOI |
10.1158/1538-7445.am2026-1822
doi
|
| 其它 |
期刊:Cancer Research 作者:Chuan Wang; Yongwang Li; Ning Zhang; Yamin Wang; Xinling Zhang; et al 出版日期:2026-04-03 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)